Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Immunocore Holdings plc (IMCR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Immunocore Holdings plc (IMCR), most recent 12 months reported: revenue $430.77M, net loss $18.07M, free cash flow -$41.15M. Latest balance sheet on file: liquid cash $880.21M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): TARSUS PHARMACEUTICALS, INC. · ADMA BIOLOGICS, INC. · Krystal Biotech, Inc. · Twist Bioscience Corporation · NOVAVAX INC · MeiraGTx Holdings plc · IOVANCE BIOTHERAPEUTICS, INC. · ADAPTIVE BIOTECHNOLOGIES CORPORATION

Stock screener

Watchlist